Intensity Therapeutics Inc (INTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,268 | -10,538 | -7,582 | -7,896 | -6,031 |
| Depreciation Amortization | 25 | 306 | 179 | 172 | 117 |
| Accounts payable and accrued liabilities | -2,268 | 1,631 | 704 | -50 | -171 |
| Other Working Capital | -2,101 | -633 | 757 | 177 | -12 |
| Other Operating Activity | 5,392 | 2,029 | 465 | 770 | 727 |
| Operating Cash Flow | $-15,220 | $-7,205 | $-5,477 | $-6,827 | $-5,370 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,354 | -6,023 | N/A | N/A | 4,565 |
| Investing Cash Flow | $6,354 | $-6,023 | $N/A | $N/A | $4,565 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 230 | 2,250 | 2,000 | N/A |
| Debt Repayment | N/A | N/A | N/A | 50 | 25 |
| Common Stock Issued | 3,553 | 20,242 | N/A | N/A | N/A |
| Other Financing Activity | -653 | 0 | 0 | 0 | 6,268 |
| Financing Cash Flow | $2,900 | $20,472 | $2,250 | $2,050 | $6,293 |
| Beginning Cash Position | 8,556 | 1,312 | 4,539 | 9,316 | 3,829 |
| End Cash Position | 2,590 | 8,556 | 1,312 | 4,539 | 9,316 |
| Net Cash Flow | $-5,966 | $7,244 | $-3,227 | $-4,777 | $5,487 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,220 | -7,205 | -5,477 | -6,827 | -5,370 |
| Free Cash Flow | -15,220 | -7,205 | -5,477 | -6,827 | -5,370 |